- Source type
- Government
- Access type
- Official
- Publisher
- U.S. Food and Drug Administration
- Date
- 2024-03-05
- Added
- 2026-07-06
- Updated
- 2026-07-06
Trust profile
VV Source Trust Matrix v1.0
VV Source Trust Matrix v1.0 asks whether this source is trustworthy for the claim lane being used, not whether every possible claim from it is equally strong.
94
U.S. health regulator
- Publisher type
- Regulator
- Bias profile
- Low
This source is strongest for regulatory status and safety and weaker for consumer context and trial discovery.
VV Source Fit Score 1.0
Fit by use case
Fit scores are role-specific. A source can be excellent for one claim lane and weak for another.
- Regulatory status
- 98/100
- Primary Anchor
- Clinical outcomes
- 84/100
- Strong Support
- Mechanism
- 68/100
- Context Source
- Safety
- 95/100
- Primary Anchor
- Consumer context
- 68/100
- Context Source
- Trial discovery
- 68/100
- Context Source
Best used for
- Approvals
- Labels
- Safety communications
Weak for
- Comparative effectiveness
- Consumer experience
Used in Viral Vitalism
CGMs for Non-Diabetics: Metabolic Radar or Anxiety Subscription?
Roles: Regulatory status
Related studies
Related sources
FDA: First Over-the-Counter Continuous Glucose Monitor for Children
Canonicalized from rapid brief fda-otc-cgm-children-dexcom-stelo.
- Trust score
- 94
- Publisher
- U.S. Food and Drug Administration
- Access
- Official
- Usage
- 1 connection
FDA: aspartame and other sweeteners in food
FDA source for approved sweeteners, acceptable daily intake framing, and the FDA view on aspartame safety.
- Trust score
- 94
- Publisher
- U.S. Food and Drug Administration
- Access
- Official
- Usage
- 3 connections
Hogan Lovells: FDA IND clearance support for Cockayne syndrome gene therapy
Regulatory-background source confirming FDA IND clearance support for the Riaan program.
- Trust score
- 60
- Publisher
- Hogan Lovells
- Access
- Publisher
- Usage
- 1 connection
Dexcom Stelo product information
Commercial source for product-positioning language, useful only to compare claims against FDA clearance and independent evidence.
- Trust score
- 60
- Publisher
- Dexcom
- Access
- Publisher
- Usage
- 2 connections
ADA Standards of Care: Diabetes technology
Professional guidance source for diabetes-technology context and why medical CGM use should not be flattened into wellness tracking.
- Trust score
- 82
- Publisher
- Diabetes Care
- Access
- Publisher
- Usage
- 6 connections
CGM as a behavior-change tool systematic review and meta-analysis
Systematic review/meta-analysis source for CGM feedback as a behavior-change intervention across populations with and without diabetes.
- Trust score
- 88
- Publisher
- International Journal of Behavioral Nutrition and Physical Activity
- Access
- Publisher
- Usage
- 7 connections